Carbogen Amcis

M&A in Pharma and CRO/CMO Industry

A Wide Spectrum of Contract Services

Opportunities in Drug Development and Manufacturing

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.

Carbogen Amcis to Expand Bubendorf

Carbogen Amcis to Take Over High-Containment Facility

A Changing World for CMOs

Mark C. Griffiths Named Carbogen Amcis CEO

Carbogen Amcis Announces Plan to Restructure

Carbogen Amcis Enhances Stability Studies Capacity

Carbogen Amcis and Eirgen Pharma Announce Partnership

Cost, Quality And Reliability

Carbogen Amcis Names Dr. Mojmir Vavrecka Chief Operating Officer